Empagliflozin improves cardiac mitochondrial function and survival through energy regulation in a murine model of heart failure.

European Journal of Pharmacology(2022)

Cited 7|Views6
No score
Abstract
Schematic figures depicting the proposed mechanisms of how empagliflozin improves heart failure by modulating the energetic cycle.Image 1
More
Translated text
Key words
Empagliflozin,SGLT2 inhibitor,Heart failure,Energy metabolism,Mitochondria
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined